Inogen, Inc.

US$6.03As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:INGNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (19.60%)
Div yield —
ROE (19.76%)
Medical Devices
Beta (5Y) 1.49
PE TTM —
TSR TTM (26.82%)
Mkt cap US$160.0M
ROIC (32.64%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.30
21.11%
(45.51%)
Hold 8|4|12|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.09
0.10
0.10
(0.27%)
2.02%
9.21%
9.03%
Revenue$M
12.79
13.50
13.15
13.26
5.28%
8.40%
7.17%
3.10%
Peers (US$160.0M)
Cap (US$)
PE
190.4M
—
163.8M
—
160.3M
—
Capital
TTM
5Y
10Y
Leveragex
0.496
—
—
EBIT/Intx
0.645
1.807
1.260
Own earn%
(24.86)
17.64
19.84
Sh yield%
54.82
40.10
39.19
Owners
Insiders/Inst%
9.92
37.13
Short interest%
2.26
SBC / revenue%
0.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
9–17
$1 testx
—
Incr. ROIC%
8